Drug intelligence / Profile preview

[11C]acetate

Development stage
Unknown
Lead developer
University of Kansas Medical Center
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[11C]acetate is a radiopharmaceutical used as a metabolic tracer in positron emission tomography (PET) imaging. It consists of the acetate anion labeled with the positron-emitting radioisotope carbon-11. In the body, acetate is a substrate for the synthesis of fatty acids and cholesterol, a process that is significantly upregulated in certain malignancies, including prostate cancer and hepatocellular carcinoma. Upon intravenous administration, [11C]acetate is transported into cells and converted into acetyl-CoA by acetyl-CoA synthetase, which is then incorporated into the lipid bilayer of cell membranes via the fatty acid synthesis pathway. This metabolic trapping allows for the detection of cancerous tissues that exhibit low glucose avidity and are therefore difficult to image with standard [18F]FDG PET. The tracer is particularly utilized in the evaluation of biochemical recurrence in prostate cancer patients, helping to guide clinical management decisions by identifying local recurrence or metastatic disease.

Other names
carbon-11 acetatecarbon11 acetatecarbon 11 acetate11C-acetate[11C]Acetate
02

Targets

ACSS2 (Acetyl-coenzyme A synthetase 2)

Beyond the preview

Go deeper on [11C]acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [11C]acetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call